List view / Grid view
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
18 June 2015 | By Victoria White
A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound - azoramide...
16 June 2015 | By Victoria White
Chemists have invented the first practical, scalable method for synthesising jiadifenolide, a molecule that may have powerful brain-protecting properties...
15 June 2015 | By Victoria White
A powerful 9.4-Tesla MRI that provides the most detailed images of the brain to date shows that brain cell density remains constant with age...
11 June 2015 | By Victoria White
Researchers have identified a naturally occurring variant of the human prion protein that produces resistance to prion diseases such as CJD...
10 June 2015 | By Victoria White
A previously unknown link between the immune system and the death of motor neurons in amyotrophic lateral sclerosis has been discovered by scientists...
Dementia is a global crisis with 76 million people worldwide expected to be living with the condition by 2030. Current symptomatic treatments provide modest improvements in cognition but disease-modifying therapies for diseases like Alzheimer’s – the most common cause of dementia – do not yet exist.
9 June 2015 | By Victoria White
A new study has revealed that calcineurin inhibitor-based medications, such as Tacrolimus or cyclosporine, may also protect against Alzheimer’s disease...
29 May 2015 | By Victoria White
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease, including early-onset Alzheimer's disease...
18 May 2015 | By Victoria White
Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...
8 May 2015 | By Victoria White
Researchers have determined the molecular structure of amyloid beta-42, one of the proteins in the brain plaques that are a hallmark of Alzheimer’s disease...
7 May 2015 | By Victoria White
University of British Columbia researchers have reported that a new anticonvulsant epilepsy drug holds promise as a treatment for Alzheimer’s disease...
29 April 2015 | By Victoria White
Inhibiting HDACs has shown significant potential in stimulating the growth of brain cells and memory restoration in animal models that mimic Alzheimer’s...
28 April 2015 | By Victoria White
A new function now described for the protein dDsk2 links ubiquitin receptors for the first time with the regulation of gene expression...
7 April 2015 | By Victoria White
Edaravone, a drug used to treat stroke victims, could help stop the progression of Alzheimer’s Disease according to new research...
